Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScRNA-Seq analysis of adult glioblastoma patient samples

ABSTRACT: scRNA-Seq analysis of adult glioblastoma patient samples

PROVIDER: PRJNA887804 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21832356.fastq.gz	Fastqsanger.gz
	SRR21832357.fastq.gz	Fastqsanger.gz
	SRR21832358.fastq.gz	Fastqsanger.gz
	SRR21832359.fastq.gz	Fastqsanger.gz
	SRR21832360.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

scRNA-Seq analysis of adult glioblastoma patient samples

Project description:Glioblastoma is the most common type of malignant brain tumor among adults. We used single-cell RNA sequencing (scRNA-seq) to analyze the diversity of glioblastoma cells.

2024-07-25 | GSE214966 | GEO

scRNA-seq of pediatric glioblastoma patient-derived xenografts

Project description:scRNA-seq of pediatric glioblastoma patient-derived xenografts

| PRJNA482625 | ENA

scRNA-seq of pediatric glioblastoma patient-derived xenografts

Project description:scRNA-seq of patient-derived xenografts.

2019-03-15 | GSE117599 | GEO

scRNA-Seq analysis of a glioblastoma patient sample after Vortioxetine or DMSO treatment

Project description:Vortioxetine is the neuroactive drug with the highest ex vivo anti-glioblastoma efficacy across patients measured in our study. We used single-cell RNA sequencing (scRNA-seq) to analyze the transcriptomic response to Vortioxetine treatment.

2024-07-29 | GSE214967 | GEO

scRNA-seq profiling of tumor microenvironment in glioblastoma patient-derived orthotopic xenogratfs (PDOXs)

Project description:scRNA-seq profiling of tumor microenvironment in glioblastoma patient-derived orthotopic xenogratfs (PDOXs)

| PRJNA940406 | ENA

scRNA-Seq analysis of a glioblastoma patient sample after Vortioxetine or DMSO treatment

Project description:scRNA-Seq analysis of a glioblastoma patient sample after Vortioxetine or DMSO treatment

| PRJNA887805 | ENA

A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1

Project description:Tumor microtubes (TMs) connect glioma cells to a network with considerable relevance for tumor progression and therapy resistance. The determination of TM-interconnectivity in individual tumors has been challenging and the impact on patient survival unresolved. Here, a connectivity signature from single-cell RNA-sequenced (scRNA-Seq) xenografted primary glioblastoma (GB) cells has been established using a dye uptake methodology, confirmed with recording of cellular calcium epochs and validated with clinical correlations. Astrocyte-like and mesenchymal-like GB cells have the highest connectivity signature scores in scRNA-sequenced patient-derived xenografts and patient samples. In large GB cohorts, network connectivity correlated with the mesenchymal subtype and dismal patient survival. CHI3L1 has been identified and validated as a robust molecular marker of connectivity with functional relevance. The connectivity signature allows novel insights into brain tumor biology, provides a proof-of-principle that tumor cell TM-connectivity is relevant for patients’ prognosis, and serves as a robust prognostic biomarker.

2023-11-27 | PXD044001 | Pride

PDGF-driven glioblastoma mouse model scRNA-Seq

Project description:Generate scRNA-Seq profiles for PDGF-driven glioblastoma mouse model.

2018-02-23 | GSE95157 | GEO

Gene expression profiling of patient-derived glioblastoma stem cell cultures

Project description:To identify proneural, neural, classical and mesenchymal gene expression signature (Verhaak's classification) in human glioblastoma, a microarray analysis on 16 patient-derived glioblastoma stem cell cultures was performed.

2018-06-26 | E-MTAB-6408 | biostudies-arrayexpress

scRNA-seq of brain glioblastoma sample

Project description:scRNA-seq of brain glioblastoma sample

| PRJNA1141154 | ENA